Hos 20 HIV- inficerede forsøgspersoner, som fik 200 mg emtricitabin daglig som hårde kapsler, var de maksimale steady- state emtricitabinkoncentrationer (Cmax) i plasma, de minimale koncentrationer (Cmin) og området under plasmakoncentrationens tidskurve over et 24- timers doseringsinterval (AUC) henholdsvis 1, 8±0, 7 µg/ ml, 0, 09±0, 07 µg/ ml og 10, 0±3, 1 µg· t/ ml.
In 20 HIV infected subjects receiving 200 mg emtricitabine daily as hard capsules, steady-state plasma emtricitabine peak concentrations (Cmax), trough concentrations (Cmin) and area under the plasma concentration time curve over a 24-hour dosing interval (AUC) were 1.8±0.7 µg/ ml, 0.09±0.07 µg/ ml and 10.0±3.1 µg·h/ ml, respectively.